Mark Herndon's most recent trade in Safeguard Scientifics, Inc. was a trade of 26,835 common stock done . Disclosure was reported to the exchange on Jan. 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Safeguard Scientifics, Inc. | Mark Herndon | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,835 | 70,625 (0%) | 0% | 0 | common stock | |
| Safeguard Scientifics, Inc. | Mark Herndon | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 17 Jan 2023 | 13,156 | 57,469 (0%) | 0% | 3.1 | 41,113 | common stock |
| Safeguard Scientifics, Inc. | Mark Herndon | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2022 | 11,526 | 49,138 (0%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Mark Herndon | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.10 per share. | 17 Jan 2022 | 5,348 | 43,790 (0%) | 0% | 7.1 | 37,971 | Common Stock |
| Safeguard Scientifics, Inc. | Mark Herndon | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2021 | 11,323 | 41,323 (0%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Mark Herndon | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.57 per share. | 20 Jan 2021 | 3,711 | 37,612 (0%) | 0% | 6.6 | 24,399 | Common Stock |